Metformin Vitabalans (Metformin Hydrochloride)

Metformin activates AMP‑activated protein kinase (AMPK), which suppresses hepatic gluconeogenesis, enhances peripheral glucose uptake, and modestly reduces intestinal glucose absorption. These actions collectively improve insulin sensitivity and lower circulating glucose.

The dose of Metformin Vitabalans is individualized by the prescribing healthcare professional based on the patient’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of Metformin during pregnancy or lactation should be evaluated by a qualified clinician. While some guidelines allow its use when benefits outweigh risks, the decision must be made on a case‑by‑case basis after thorough medical assessment.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin is often preferred as first‑line therapy for type 2 diabetes because it does not cause weight gain and has a low risk of hypoglycemia compared with sulfonylureas or insulin. Its cardiovascular safety profile is also favorable relative to many other oral agents.

Metformin Vitabalans should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat to maintain its stability and potency.

Metformin Vitabalans is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets should be swallowed whole with a glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, dehydration, or excessive alcohol intake. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain or unexplained fatigue develop.

Metformin is contraindicated in individuals with known hypersensitivity to metformin, severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, and certain conditions that predispose to lactic acidosis. A healthcare professional should evaluate suitability before initiating therapy.